1.1K(top 1%)
papers
43.1K(top 1%)
citations
87(top 1%)
h-index
193(top 1%)
g-index
1.3K
all documents
53.7K
doc citations
5.8K
citing journals

Top Articles

#TitleJournalYearCitations
1Minimal information for studies of extracellular vesicles 2018 (MISEV2018): a position statement of the International Society for Extracellular Vesicles and update of the MISEV2014 guidelinesJournal of Extracellular Vesicles20189,284
2Towards a unified paradigm for sequence‐based identification of fungiMolecular Ecology20133,472
3Improved software detection and extraction of ITS1 and ITS2 from ribosomal ITS sequences of fungi and other eukaryotes for analysis of environmental sequencing dataMethods in Ecology and Evolution20131,318
4Neurofilament light chain as a biomarker in neurological disordersJournal of Neurology, Neurosurgery and Psychiatry20191,063
5Serum Neurofilament light: A biomarker of neuronal damage in multiple sclerosisAnnals of Neurology20171,021
6Biomarkers for Alzheimer's disease: current status and prospects for the futureJournal of Internal Medicine2018815
7CSF biomarkers of Alzheimer's disease concord with amyloid‐β PET and predict clinical progression: A study of fully automated immunoassays in BioFINDER and ADNI cohortsAlzheimer's and Dementia2018696
8Vascular dysfunction—The disregarded partner of Alzheimer's diseaseAlzheimer's and Dementia2019601
9The consequences of fetal growth restriction on brain structure and neurodevelopmental outcomeJournal of Physiology2016517
10sTREM 2 cerebrospinal fluid levels are a potential biomarker for microglia activity in early‐stage Alzheimer's disease and associate with neuronal injury markersEMBO Molecular Medicine2016487
11Increased burden of ultra-rare protein-altering variants among 4,877 individuals with schizophreniaNature Neuroscience2016475
12Core candidate neurochemical and imaging biomarkers of Alzheimer's diseaseAlzheimer's and Dementia2008473
13Protective Role of Reactive Astrocytes in Brain IschemiaJournal of Cerebral Blood Flow and Metabolism2008470
14Duration of preclinical, prodromal, and dementia stages of Alzheimer's disease in relation to age, sex, and APOE genotypeAlzheimer's and Dementia2019469
15International criteria for electrocardiographic interpretation in athletes: Consensus statementBritish Journal of Sports Medicine2017421
16CSF Aβ42/Aβ40 and Aβ42/Aβ38 ratios: better diagnostic markers of Alzheimer diseaseAnnals of Clinical and Translational Neurology2016407
17Salivary secretion in health and diseaseJournal of Oral Rehabilitation2018406
18Timing of high-efficacy therapy for multiple sclerosis: a retrospective observational cohort studyLancet Neurology, The2020373
19CSF biomarker variability in the Alzheimer's Association quality control programAlzheimer's and Dementia2013365
20Progress toward standardized diagnosis of vascular cognitive impairment: Guidelines from the Vascular Impairment of Cognition Classification Consensus StudyAlzheimer's and Dementia2018353
21Novel tau biomarkers phosphorylated at T181, T217 or T231 rise in the initial stages of the preclinical Alzheimer’s continuum when only subtle changes in Aβ pathology are detectedEMBO Molecular Medicine2020344
22Technical performance of a novel, fully automated electrochemiluminescence immunoassay for the quantitation of β‐amyloid (1–42) in human cerebrospinal fluidAlzheimer's and Dementia2016329
23The “Saltin–Grimby Physical Activity Level Scale” and its application to health researchScandinavian Journal of Medicine and Science in Sports2015314
24Cerebrospinal fluid levels of the synaptic protein neurogranin correlates with cognitive decline in prodromal Alzheimer's diseaseAlzheimer's and Dementia2015302
25The cerebrospinal fluid “Alzheimer profile”: Easily said, but what does it mean?Alzheimer's and Dementia2014274
26Update on the biomarker core of the Alzheimer's Disease Neuroimaging Initiative subjectsAlzheimer's and Dementia2010266
27Blood‐based biomarkers in Alzheimer disease: Current state of the science and a novel collaborative paradigm for advancing from discovery to clinicAlzheimer's and Dementia2017263
28Cerebrospinal fluid tau, neurogranin, and neurofilament light in Alzheimer's diseaseEMBO Molecular Medicine2016259
29Consensus guidelines for lumbar puncture in patients with neurological diseasesAlzheimer's and Dementia: Diagnosis, Assessment and Disease Monitoring2017252
30Lipopolysaccharide‐induced alteration of mitochondrial morphology induces a metabolic shift in microglia modulating the inflammatory response in vitro and in vivoGlia2019238
31Performance and complications of lumbar puncture in memory clinics: Results of the multicenter lumbar puncture feasibility studyAlzheimer's and Dementia2016226
32One-year outcome in the European multicentre study on iNPHActa Neurologica Scandinavica2012206
33Amyloid beta, tau, synaptic, neurodegeneration, and glial biomarkers in the preclinical stage of the Alzheimer's continuumAlzheimer's and Dementia2020204
34The European iNPH Multicentre Study on the predictive values of resistance to CSF outflow and the CSF Tap Test in patients with idiopathic normal pressure hydrocephalusJournal of Neurology, Neurosurgery and Psychiatry2013201
35The Vascular Impairment of Cognition Classification Consensus StudyAlzheimer's and Dementia2017201
36Plasma neurofilament light chain predicts progression in progressive supranuclear palsyAnnals of Clinical and Translational Neurology2016198
37Alcohol withdrawal syndrome: mechanisms, manifestations, and managementActa Neurologica Scandinavica2017195
38Characterization of pre‐analytical sample handling effects on a panel of Alzheimer's disease–related blood‐based biomarkers: Results from the Standardization of Alzheimer's Blood Biomarkers (SABB) working groupAlzheimer's and Dementia2022191
39Plasma and CSF biomarkers in a memory clinic: Head‐to‐head comparison of phosphorylated tau immunoassaysAlzheimer's and Dementia2023187
40Inflammatory biomarkers in Alzheimer's disease plasmaAlzheimer's and Dementia2019178
41Pathways to Alzheimer's diseaseJournal of Internal Medicine2014176
42Insulin‐like growth factor 1 has multisystem effects on foetal and preterm infant developmentActa Paediatrica, International Journal of Paediatrics2016167
43Cerebrospinal fluid neurogranin and YKL ‐40 as biomarkers of Alzheimer's diseaseAnnals of Clinical and Translational Neurology2016166
44Detecting amyloid positivity in early Alzheimer's disease using combinations of plasma Aβ42/Aβ40 and p‐tauAlzheimer's and Dementia2022165
4518F‐AV‐1451 and CSF T‐tau and P‐tau as biomarkers in Alzheimer's diseaseEMBO Molecular Medicine2017164
46The effect of neurodegenerative diseases on the subventricular zoneNature Reviews Neuroscience2007163
47Alcohol consumption and alcohol problems after bariatric surgery in the swedish obese subjects studyObesity2013163
48Plasma amyloid β 40/42 ratio predicts cerebral amyloidosis in cognitively normal individuals at risk for Alzheimer's diseaseAlzheimer's and Dementia2019159
49Elevated CSF GAP‐43 is Alzheimer's disease specific and associated with tau and amyloid pathologyAlzheimer's and Dementia2019156
50Bipolar disorder and its relation to major psychiatric disorders: a family‐based study in the Swedish populationBipolar Disorders2015155